Skip to main content

Table 1 Characteristics of the patients enrolled in the study

From: Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

Patient #

Sampling: pre, post dose#

Course/ Cycle of Sampling

Response

Biological Response

# of doses

p1

pre, post 1

c1c2

SD 2C

NR

3

p2

pre, post 1, post 4

c3c1

SD 2C

NR

8

p3

pre, post 1, post 5

c3c1

PR 1C CR 3C

BR

5

p4

pre, post 1, post 4

c2c1

PR 1C SD 2C PD

BR

7

p5

pre, post 1, post 4

c1c2

SD 1C PD 2C

NR

6

p6

pre, post 1

c1c2

PR 2C PD 3C

BR

4

p7

pre, post 1

c2c1

SD 1C

NR

4

p8

pre

c1c1

PD 1C

NR

8

p9

pre, post 1, post 4

c1c1

PD 1C

NR

7

p10

pre, post 1

c1c2

MR 1C

BR

7

p11

pre, post 1

c3c2

SD 1C PR 3C

NR

3

p12

pre, post 1, post 4

c1c1

SD

NR

8

p13

pre, post 1, post 4

c1c1

PD 1C

NR

7

p14

pre, post 1, post 4

c2c1

MR 1C

BR

8

p15

pre, post 1, post 4

c1c1

MR 1C

BR

7

p16

pre, post 1, post 4

c1c1

PD

NR

9

  1. C = course; CR = complete response; SD = stable disease; PR = partial response; MR = mixed response; PD = progressive disease; BR Biological response = CR+PR+MR; NR = Non responder = PD+SD